Praxis Precision Medicines's market cap is currently ―. The company's EPS TTM is $-23.651; its P/E ratio is -2.58; Praxis Precision Medicines is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-2.07. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 515.00K	$ 468.00K	$ 781.00K	$ 683.00K	-
Gross Profit	$ 515.00K	$ 468.00K	$ 781.00K	$ 683.00K	-
EBIT	$ -26.88M	$ -24.63M	$ -34.31M	$ -37.45M	$ -42.13M
EBITDA	$ -26.55M	$ -24.31M	$ -34.00M	$ -37.10M	$ -41.65M
Net Income Common Stockholders	$ -26.90M	$ -24.63M	$ -34.31M	$ -37.45M	$ -41.17M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 81.30M	$ 101.10M	$ 124.30M	$ 85.82M	$ 100.49M
Total Assets	$ 87.95M	$ 106.72M	$ 133.50M	$ 97.52M	$ 115.13M
Total Debt	$ 2.50M	$ 2.76M	$ 3.01M	$ 3.26M	$ 3.50M
Net Debt	$ -78.81M	$ -98.34M	$ -121.29M	$ -82.56M	$ -96.99M
Total Liabilities	$ 18.28M	$ 19.97M	$ 27.87M	$ 33.91M	$ 39.02M
Stockholders Equity	$ 69.67M	$ 86.76M	$ 105.64M	$ 64.47M	$ 76.11M
Cash Flow	-
Free Cash Flow	$ -23.91M	$ -23.21M	$ -31.17M	$ -32.89M	$ -28.81M
Operating Cash Flow	$ -23.86M	$ -23.21M	$ -31.17M	$ -32.89M	$ -28.81M
Investing Cash Flow	$ -50.00K	-	$ 5.00M	$ 34.00M	$ 22.59M
Financing Cash Flow	$ 4.13M	-	$ 69.67M	$ 18.07M	$ 5.39M

Currency in USD

Praxis Precision Medicines Earnings and Revenue History

Income Statement >

Praxis Precision Medicines Debt to Assets

Balance Sheet >

Praxis Precision Medicines Cash Flow

Cash Flow >

Praxis Precision Medicines Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing